Redmile Group’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Redmile Group's ADRX Position: Q3 2026 in Review
Redmile Group opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 769,345 shares worth $15.3M. The stake represents 1.12% of the portfolio and ranks #18 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Redmile Group held 769,345 shares of ADARx Pharmaceuticals worth $15.3M as of Q3 2026.
- ADARx Pharmaceuticals was a new Redmile Group position in Q3 2026.
- ADARx Pharmaceuticals made up 1.12% of Redmile Group's portfolio in Q3 2026, its #18 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.